EUVIMEDEUVIMED entdecken
Kontrollierte klinische StudieOpen Access · CC BY 4.0

A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS/atropine

Paolo Nucci, Andrea Lembo, Irene Schiavetti, Rakhee Shah, David Francis Edgar, Bruce John William Evans iD

PLOS ONE · 16.02.2023 · 18 (2) · e0281816

DOI: 10.1371/journal.pone.0281816 ↗

Kurz gefasst

Kontrollierte klinische Studie in der Zeitschrift PLOS ONE, online erschienen am 16.02.2023. Verfasst von Paolo Nucci und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy. Hauptthemen laut MEDLINE: Atropine, Myopia. Die Arbeit wurde bisher 109-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute of Optometry.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate the efficacy of a myopia control spectacle lens (DIMS) at slowing the progression of myopia in a population of European children in comparison with 0.01% atropine and combined DIMS and atropine.

Methods

The study was a non-randomised experimenter-masked prospective controlled observational study of individuals aged 6–18 years with progressing myopia but no ocular pathology. Participants were allocated, according to patient/parent choice, to receive 0.01% atropine eyedrops, DIMS (Hoya ® MiyoSmart ® ) spectacles, combined atropine+DIMS or single vision spectacle lenses (control group). The key outcome variables, cycloplegic autorefraction spherical equivalent refraction (SER) and axial length (AL), were measured at baseline and after three, six, and 12 months.

Results

Of the 146 participants (mean age 10.3y ±3.2), 53 received atropine, 30 DIMS spectacles, 31 atropine+DIMS, and 32 single vision control spectacles. Generalized linear mixed model analysis revealed for SER, whilst controlling for age and SER at baseline, at each stage all treatment groups had significantly reduced progression compared with the control group (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtropineMyopiaAdolescentChildHumansDisease ProgressionEyeglassesProspective StudiesRefraction, Ocular

Substanzen

Atropine

Autor:innen und Institutionen

  • Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
  • Department of Biomedical, Surgical and Dental Sciences, University of Milan San Giuseppe Hospital, Milan, Italy.
  • Department of Health Sciences, Section of Biostatistics, University of Genoa, Genoa, Italy.
  • Research Department, Institute of Optometry, London, United Kingdom.
  • Department of Optometry and Visual Sciences, School of Health and Psychological Sciences, University of London, London, United Kingdom.

ORCID-Profile: Bruce John William Evans

Förderung

  • Institute of Optometry

Zitieren

APA

Nucci, P., Lembo, A., Schiavetti, I., Shah, R., Edgar, D. F., & Evans, B. J. W. (2023). A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS/atropine. PLOS ONE, 18(2), e0281816. https://doi.org/10.1371/journal.pone.0281816

Vancouver

Nucci P, Lembo A, Schiavetti I, Shah R, Edgar DF, Evans BJW. A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS/atropine. PLOS ONE. 2023;18(2):e0281816. doi:10.1371/journal.pone.0281816

BibTeX
@article{Nucci2023,
  author = {Nucci, Paolo and Lembo, Andrea and Schiavetti, Irene and Shah, Rakhee and Edgar, David Francis and Evans, Bruce John William},
  title = {A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS/atropine},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {2},
  pages = {e0281816},
  doi = {10.1371/journal.pone.0281816}
}
Kostenlos starten →